EUVIMEDEUVIMED entdecken
Crossref

Skin cancer in Europe today and challenges for tomorrow

Lieve Brochez iD, Beate Volkmer iD, Isabelle Hoorens iD, Claus Garbe iD, Martin Röcken iD, Joachim Schüz iD, David C Whiteman, Philippe Autier iD, Rüdiger Greinert, Brigitta Boonen iD

Journal of the European Academy of Dermatology and Venereology · 2025-02 · 39 (2) · 272-277

DOI: 10.1111/jdv.20368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 08.10.2024. Verfasst von Lieve Brochez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Skin Neoplasms. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One in every three cancers diagnosed is a skin cancer. Europe has the global lead in the number of UV‐attributable cancer cases with the highest number of melanoma cases worldwide and the second highest number of keratinocyte cancers (KC). Further increases are expected in Europe for the coming decades. Projected increases are highest for KC with increases in incidence around 40% and increases in mortality around 50%, with KC mortality in males approximating melanoma mortality in females. The two main drivers for this skin cancer epidemic are ageing of the population but especially UV exposure. In conclusion, skin cancer represents a major challenge in the cancer field in Europe today and will continue to do so in the coming decades. This calls for a European skin cancer action plan intended to reduce avoidable UV exposure and to prepare the healthcare system to safeguard early diagnosis and treatment of skin cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsFemaleHumansMaleEuropeIncidenceMelanomaUltraviolet Rays

Autor:innen und Institutionen

  • Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Skin Cancer Research Institute Ghent (Skin CRIG), Ghent, Belgium.
  • Department of Molecular Cell Biology, Skin Cancer Center Buxtehude, Elbekliniken Stade/Buxtehude, Buxtehude, Germany.
  • Centre for Dermato-Oncology, University Hospital Tübingen, Tübingen, Germany.
  • Dermatology, University Hospital Tübingen, Tübingen, Germany.
  • Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

ORCID-Profile: Lieve Brochez, Beate Volkmer, Isabelle Hoorens, Claus Garbe, Martin Röcken, Joachim Schüz, Philippe Autier, Brigitta Boonen

Förderung

  • World Health Organization

Zitieren

APA

Brochez, L., Volkmer, B., Hoorens, I., Garbe, C., Röcken, M., Schüz, J., Whiteman, D. C., Autier, P., Greinert, R., & Boonen, B. (2025). Skin cancer in Europe today and challenges for tomorrow. Journal of the European Academy of Dermatology and Venereology, 39(2), 272-277. https://doi.org/10.1111/jdv.20368

Vancouver

Brochez L, Volkmer B, Hoorens I, Garbe C, Röcken M, Schüz J, et al. Skin cancer in Europe today and challenges for tomorrow. Journal of the European Academy of Dermatology and Venereology. 2025;39(2):272-277. doi:10.1111/jdv.20368

BibTeX
@article{Brochez2025,
  author = {Brochez, Lieve and Volkmer, Beate and Hoorens, Isabelle and Garbe, Claus and Röcken, Martin and Schüz, Joachim and Whiteman, David C and Autier, Philippe and Greinert, Rüdiger and Boonen, Brigitta},
  title = {Skin cancer in Europe today and challenges for tomorrow},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  volume = {39},
  number = {2},
  pages = {272--277},
  doi = {10.1111/jdv.20368}
}
Kostenlos starten →